STRUCTURE THERAPEUTICS INC (GPCR) Stock Earnings & Estimates
USA - NASDAQ:GPCR - US86366E1064 - ADR
26.04 USD
-1.96 (-7%)
26.38 USD
+0.34 (+1.31%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A | N/A 159.73% | N/A 43.07% | N/A 52.02% | N/A 52.79% | ||||||
| EBITDA YoY % growth | -15.906M | -37.624M -136.54% | -52.284M -38.96% | -102.48M -96.01% | -157.236M -53.43% | N/A -80.30% | N/A -15.69% | N/A -14.44% | N/A 0.38% | N/A 42.92% | N/A 132.80% | N/A 525.83% | N/A 121.70% | |
| EBIT YoY % growth | -15.906M | -37.696M -136.99% | -52.561M -39.43% | -102.775M -95.53% | -158.228M -53.96% | N/A -76.08% | N/A -21.84% | N/A -15.20% | N/A 28.98% | N/A 89.22% | N/A 968.11% | N/A 136.91% | N/A 95.53% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -2.13 40.84% | -2.02 5.16% | N/A 31.63% | N/A -26.67% | N/A -3.12% | N/A -7.55% | N/A 90.64% | N/A 885.39% | N/A 141.63% | N/A 93.78% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.37 38.98% | -0.39 43.04% | -0.42 48.37% | -0.43 60.65% | -0.42 -13.54% | -0.42 -5.88% | -0.39 7.32% | -0.39 8.80% | -0.39 6.75% | -0.38 9.31% | -0.38 2.63% | -0.38 2.63% |
| Revenue Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | ||||||
| EBITDA Q2Q % growth | -78.659M -74.35% | -76.872M -66.86% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -73.858M -61.13% | -77.133M -63.90% | -83.127M -47.62% | -85.064M -20.74% | -84.594M -14.54% | -87.087M -12.90% | N/A | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -1.08 -100.00% | -0.28 | -0.80 | -283.91% |
| Q1 2025 Q2Q % growth | -0.81 -326.32% | -0.23 | -0.58 | -246.94% |
| Q4 2024 Q2Q % growth | -0.69 -4.55% | -0.23 | -0.46 | -202.27% |
| Q3 2024 Q2Q % growth | -0.60 3.23% | -0.19 | -0.41 | -216.46% |
| Q2 2024 Q2Q % growth | -0.54 10.00% | -0.23 | -0.31 | -133.22% |
| Q1 2024 Q2Q % growth | -0.19 24.00% | -0.21 | 0.02 | 11.60% |
| Q4 2023 Q2Q % growth | -0.66 42.11% | -0.21 | -0.45 | -211.09% |
| Q3 2023 Q2Q % growth | -0.62 | -0.30 | -0.32 | -108.76% |
| Q2 2023 Q2Q % growth | -0.60 | -0.28 | -0.32 | -112.05% |
| Q1 2023 Q2Q % growth | -0.25 | -0.42 | 0.17 | 40.70% |
| Q4 2022 Q2Q % growth | -1.14 | -0.84 | -0.30 | -36.30% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2022 Q2Q % growth | 7.038M | -7.038M | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 3.37% | -24.02% | 1.89% | -26.73% |
| Revenue | N/A | N/A | N/A | N/A |